Blog April 10, 2020
In this session of efp Barcelona 2020, two of the biggest names in pharma, MSD and Roche, shared their own unique digital experiences in hopes of teaching and inspiring others.
Blog April 10, 2020
Interested in how life science companies are approaching patient-centricity at eyeforpharma Barcelona 2020? We’ve got you covered with a dozen soundbites from the session.
Blog April 8, 2020
The FDA approved Biohaven Pharmaceuticals’ migraine therapy, Nurtec, last month, just before the COVID-19 pandemic sent people the world over into lockdown.
Blog March 31, 2020
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
Blog March 31, 2020
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it. They were developing a vaccine technology that could be modified to inoculate against a variety of viruses in poultry.
Blog March 17, 2020
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
Blog March 10, 2020
The advent of federal regulatory guidelines for developing gene therapies—which transplant new genes into people’s cells in order to correct disorders—is a crucial moment in the narrative of the still-novel treatment type.
Blog March 2, 2020
Following just a few years after its 2016 digital health research report, the American Medical Association’s most recent study of the use and adoption of digital clinical tools is proving that more and more physicians are becoming increasingly open to emerging technology.
Blog February 25, 2020
The Cost of Mental Health, Turnover, and Bullying in the Workplace
Blog February 24, 2020
Four promising innovations make the British Heart Foundation’s Big Beat Challenge shortlist.
Blog February 21, 2020
As voice-based commerce is on the rise – thanks to popular digital assistants like Amazon’s Alexa - brands can now leverage a new synthetic voice feature that adds an extra touch of personalization to the experience.
Blog February 12, 2020
Debuting at CES 2020, the AR-based smart mirror leverages immersive technology that connects with personal care devices, apps and professionals to help consumers make smart choices about their health – all from the convenience of their home.
Blog February 10, 2020
At the annual meeting of the World Economic Forum (WEF), AstraZeneca announced a powerful new initiative comprised of a five-year plan and a ten-year plan.
Blog January 30, 2020
From augmented to virtual reality, brands are leveraging video-game-like tech to evolve the training experience for doctors around the world.
Blog January 27, 2020
Pharmaceutical companies across the globe are finding the channels through which they can get desperately needed treatments to patients in need at humane prices.
Blog January 17, 2020
Marked demographic shifts among American doctors are forecasting a new future for the profession. According to the Association of American Medical Colleges, women applicants to medical schools in the U.S. outnumbered men last year, 51-49%.
Blog January 10, 2020
Welcome to 2020. It’s a new year and a new decade. With that we have another year of critical shifts across the health landscape. These trends are critical to understand as we move forward into our next decade of innovation, opportunity and influence.
Blog January 9, 2020
When it comes to a cancer diagnosis, accuracy is a key element in receiving timely and effective care. With Google Health’s new algorithm for analyzing x-rays, AI can provide a helping hand to radiologists to prevent missed or false diagnoses.
Blog January 2, 2020
We’ve broken down some of the biggest healthcare stories of 2019. There’s something for everyone complete with a few predictions for 2020.
Blog December 23, 2019
A French health tech company is working on the commercial launch of a smart t-shirt, named Nexkin, designed to track six key physiological indicators in order to help with risk reduction and prevention programs.
Blog December 23, 2019
Funding for federal gun violence research and an early holiday present for biosimilars manufacturers -- We break down the new federal budget as well as news from the ACA’s legal saga in this week’s edition of The Week That Was.
Blog December 20, 2019
Speaking at Sanofi’s U.S. headquarters, Dr. Gaurang Daftary, senior director of medical affairs at Ferring Pharmaceuticals, stressed how much women’s health has suffered due to the fact that, historically, clinical trials have recruited mostly men.
Blog December 18, 2019
You’ve heard of a hotline, but what about a “warmline”? For about 30 states around the U.S., warmlines are emerging as the new intermediary step people can use before reaching a mental health crisis.
Blog December 17, 2019
Did you hear that the US House of Representatives passed H.R. 3, the Lower Drug Costs Now Act, a sweeping bill designed to lower drug prices? We detail the bill and what it could mean for life sciences companies in this week's edition of The Week That Was.
Blog December 13, 2019
A new study suggests we may be consuming more BPA than previously thought. Using a direct method to analyze metabolites paints a much clearer picture of BPA levels in our diets.
Blog December 12, 2019
When Amazon first bought the online pharmacy PillPack, in 2018, many began wondering about the precise nature of Amazon’s health care ambitions. At last, some customers are now experiencing Amazonian health care firsthand.
Blog December 9, 2019
Uber recently released a safety report and announced steps it plans to take to address sexual assault in ride shares and provide support for victims. We dig into their reputation repair campaign and how it’s impacting the competition in this week’s The Week That Was.
Blog December 4, 2019
In early November, thousands of people from around the world gathered together in Dubai to get first-hand access to a class of innovators designing solutions for a better world.
Blog November 27, 2019
The revolutionary look and feel of many modern clinical trials are exemplified by three new studies from a very powerful sponsor: Apple.
Blog November 25, 2019
A consortium of 300 powerful organizations have filed resolutions demanding research into the feasibility of tying drug pricing to senior executive incentive pay. Read about this and much more in this week’s edition of The Week That Was.
Already have a RSS feed reader?
